☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Nuance Pharma
Nuance Pharma Initiates the First Patient Dosing of Ensifentrine in P-III for the Treatment of Chronic Obstructive Pulmonary Disea...
April 7, 2023
Nuance Pharma Signs a License and Supply Agreement with Bavarian Nordic to Develop and Commercialize of Respiratory Syncytial Viru...
March 21, 2022
PharmaShots Weekly Snapshots (June 07 - 11, 2021)
June 11, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
